
EMBL sells ViraTherapeutics to trade for €210m
Heidelberg-based life sciences VC firm EMBL Ventures has sold its stake in biotechnology company ViraTherapeutics to pharmaceuticals business Boehringer Ingelheim in a transaction valuing the business at €210m.
Latest News
Idinvest et al. inject €25m in Malt series-B
VCs Serena and Isai re-up, having previously backed the €5m series-A in 2016
Alto Partners acquires Bia
Third investment made by Alto Capital IV, which held a €210m final close in 2018
Ex-HQ Capital CEO moves to Schroders
Based in London and Frankfurt, Wunderlin will report to group chief executive Peter Harrison
Ardian’s Revima completes two bolt-ons
Ardian bought a majority stake in France-based Revima from Argos Wityu last month
Back to Top